investorscraft@gmail.com

Intrinsic Value of Haemonetics Corporation (HAE)

Previous Close$89.22
Intrinsic Value
Upside potential
Previous Close
$89.22

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2023-03-31 and quarterly data as of 2023-06-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2024202520262027202820292030203120322033203420352036203720382039204020412042204320442045204620472048

INCOME STATEMENT

Revenue growth rate, %17.7NaN
Revenue, $1169NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m1013NaN
Operating income, $m156NaN
EBITDA, $m251NaN
Interest expense (income), $mNaN
Earnings before tax, $m141NaN
Tax expense, $m26NaN
Net income, $m115NaN

BALANCE SHEET

Cash and short-term investments, $m284NaN
Total assets, $m1935NaN
Adjusted assets (=assets-cash), $m1650NaN
Average production assets, $m1044NaN
Working capital, $m518NaN
Total debt, $m773NaN
Total liabilities, $m1117NaN
Total equity, $m818NaN
Debt-to-equity ratio0.945NaN
Adjusted equity ratio0.335NaN

CASH FLOW

Net income, $m115NaN
Depreciation, amort., depletion, $m95NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m273NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-109NaN
Free cash flow, $m382NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m518
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount